Eligibility for ACOSOG Z0011 Trial and Results on a Cohort of 3546 Breast Cancer Patients with Micro or Macro Metastases Sentinel Nodes

Since results of ACOSOG-Z0011 and IBCSG-23-01 trials, complementary Axillary Lymph Node Dissection (cALND) was questioned for Breast Cancer (BC) with involved Sentinel Node (SN). We examine eligibility rate to Z0011-trial criteria and results among patients with SN micro or macro-metastases....